Cytokine gene polymorphisms in inflammatory bowel disease

Gut

Volumn 39, Issue 5, 1996, Pages 705-710

  Louis, E ^a   Satsangi, J ^a   Roussomoustakaki, M ^a   Parkes, M ^a   Fanning, G ^b   Welsh, K ^b   Jewell, D ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Crohn's disease; Cytokine gene polymorphisms; Immunogenetics; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0030478984     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.5.705     Document Type: Article

References (26)

1. McConnell RB, Vadheim CM. Inflammatory bowel disease. In: King RA, Rotter JI, Motulsky AO, ed. The genetic basis of common diseases. Oxford: Oxford University Press, 1992: 326-48.
2. Tysk C, Lindberg E, Järnerot G, Flodérus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 28: 990-6.
3. Satsangi J, Rosenberg WMC, Jewell DP. The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Eur J Gastroenterol Hepatol 1994; 6: 413-6.
4. Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994; 35: 696-700.
5. Asakura H, Tsuchiya M, Aiso S, et al. Association of human leucocyte DR2 antigen with Japanese ulcerative colitis. Gastroenterology 1982; 82: 413-8.
6. Toyoda H, Wang S-J, Yang H, Redford A, Magalong D, Tyan D, et al. Distinct association of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104: 741-8.
7. Duerr RH, Neigut DA. Molecularly denned HLA-DR2 alleles in ulcerative colitis and an anti-neutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995; 108: 423-7.
8. Satsangi J, Welsh KI, Bunce M, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1212-7.
9. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995; 154: 2434-40.
10. Tarlow JK, Blakemore AIF, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 9: 403-4.
11. Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-42.
12. Tarlow JK, Blakemore AIF, Cork MJ, Messenger A, McDonagh A, Bleehen SS. Association between interleukin-1 receptor antagonist (IL1-RA) gene polymorphism and chronic inflammatory diseases. Lymphokine Cytokine Research 1993; 12: A181.
13. Wilson AG, de Vries N, Pociot F, de Giovine FS, Van Der Putte LBA, Duff GW. An allelic polymorphism within the human tumour necrosis factor-alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993; 177: 557-60.
14. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW. Effects of a tumour necrosis factor-α (TNF-α) promoter base transition on transcriptional activity. Br J Rheumatol 1994; 33: 89.
15. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkovski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-11.
16. Bunce M, Taylor CJ, Welsh KI. Rapid HLA-DQB typing by eight PCR amplifications with sequence-specific primers (PCR-SSP). Hum Immunol 1993; 37: 201-6.
17. Verjans GMGM, Brinkman BMN, van Doornik CEM, Kijlstra A, Verweij CL. Polymorphism of tumour necrosis factor-α (TNF-α) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994; 97: 45-7.
18. Bioque G, Monteleone G, Crusius JBA, et al. Further evidence fora genetic association of interleukin-1 receptor antagonist with ulcerative colitis in a Northern and a Mediterranean population. Gastroenterology 1995; 108: A783.
19. Andus T, Caesar I, Vogl D, Scholmerich J, Gross V. Association of HLA-DR15, pANCA and IL-1 receptor antagonist allele 2 with ulcerative colitis. Gastroenterology 1995; 108: A770.
20. Tountas NA, Kam L, di Giovine FS, Casini-Raggi V, Cominelli F. Genetic association between allele 2 of IL-1 receptor antagonist (IL-1RA) and ulcerative colitis in a Los Angeles based Hispanic population. Gastroenterology 1995; 108: A930.
21. Duerr RH, Tran T. Association between ulcerative colitis and a polymorphism in intron 2 of the interleukin-1 receptor antagonist gene. Gastroenterology 1995; 108: A812.
22. Langholz E, Nielsen OH, Munkholm P, Davidsen M, Binder V. Course and prognostic factors influencing anatomical extent of ulcerative colitis. Gastroenterology 1995; 108: A857.
23. Roussomoustakaki M, Louis E, Satsangi J, Mortensen NJM, Kettlewell MGW, Jewell DP. Cytokine genepolymorphisms in patients with an ileal pouch anal anastomosis (IPAA) for ulcerative colitis. Gut 1995; 37(suppl 2): A415.
24. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1RA) gene polymorphism. Clin Exp Immunol 1995; 99: 303-10.
25. Nedospasov SA, Udalova IA, Kujrash DV, Turetskayar RL. DNA sequence polymorphism at the human tumour necrosis factor (TNF) locus. J Immunol 1991; 147; 1053-9.
26. Weissenbach J, Gyapay G, Dib C, et al. A second generation linkage map of the human genome. Nature 1992; 359: 794-801.